D&C RED NO. 30

Substance profile for UNII 2S42T2808B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for D&C RED NO. 30
Structure render from PubChem CID 3000709

Substance Identity#

UNII
2S42T2808B
Preferred term
D&C RED NO. 30
Registry number
2379-74-0
EC number
219-163-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C18H10Cl2O2S2
Chemical structure for D&C RED NO. 30
Structure render from PubChem CID 3000709

Chemical And Database Identifiers#

InChIKey
NDDLLTAIKYHPOD-ISLYRVAYSA-N
SMILES
CC1=CC(Cl)=CC2=C1C(=O)\C(S2)=C3/SC4=CC(Cl)=CC(C)=C4C3=O
RxCUI
1311176
PubChem
3000709
NCIt
C71661
INN ID
0

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BLOVASTATIN TABLETS, USP 40-8843 Revised – January 2008 Rx Only2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMetoprolol Tartrate Tabs1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BInflamation Reduction Pack2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDIVALPROEX SODIUM2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAMOXICILLIN - amoxicillin tablet, film coated1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMETOPROLOL TARTRATE TABLETS USP 0733 07341
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BEstradiol Tablets USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMETOPROLOL TARTRATE - metoprolol tartrate tablet, film coated Rubicon Research Private Limited4
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BSelect Brand Ultra Strength Assorted Fruit Antacid Tablets1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAntacid Tablets Regular Strength Assorted Fruit2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BSelect Brand Extra strength Gas Relief Cherry Creme Tablets1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BIsotretinoin Capsules USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BThese highlights do not include all the information needed to use amoxicillin safely and effectively. See full prescribing information for amoxicillin. Amoxicillin Capsules, Tablets, and Powder for Oral Suspension Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.3
D&C red no. 30INACTIVE INGREDIENT2S42T2808BFruit Smoothies ®1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BLIPSTICK QUEEN ENDLESS SUMMER Broad Spectrum SPF 15 Sunscreen1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Befbc79b9-c07c-40e3-ad8b-9bced4c93aa51
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bbe67ff48-8e43-4589-800b-7c67d0c36cea1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bb32fcb1b-fee4-44b8-a91c-10dfdd3f84ea3
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BEstradiol Tablets USP3
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BSYNTHROID® (levothyroxine sodium tablets, USP)5
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCalcium antacid regular strength1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMetoprolol Tartrate Tablets USP Rx Only Prescribing Information7
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDivalproex Sodium Delayed Release Tablets USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDRUG FACTS1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BThese highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAmerica*s Choice Oil-Free Acne Wash1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BThese highlights do not include all the information needed to use amoxicillin safely and effectively. See full prescribing information for amoxicillin. Amoxicillin Capsules, Tablets, and Powder for Oral Suspension Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bdc9f4282-1cd8-4f67-9dfc-ad627453256c1
D&C red no. 30INACTIVE INGREDIENT2S42T2808BFruit Smoothies ®1
D&C red no. 30INACTIVE INGREDIENT2S42T2808BFruit Smoothies ®1
D&C red no. 30INACTIVE INGREDIENT2S42T2808BFruit Smoothies ®1
D&C red no. 30INACTIVE INGREDIENT2S42T2808BFruit Smoothies ®1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BLevoxyl ® (levothyroxine sodium tablets, USP)5
D&C red no. 30INACTIVE INGREDIENT2S42T2808BBlistex (Fruit Smoothies)1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDRUG FACTS1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDRUG FACTS1
D&C red no. 30INACTIVE INGREDIENT2S42T2808BFruit Smoothies ®1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMETOPROLOL TARTRATE TABLETS USP 0733 07341
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP CIII Rx only2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BThese highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BChlorproMAZINE Hydrochloride Tablets, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BBest Choice ® Oil-Free Acne Wash Foaming Scrub1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BImipramine Hydrochloride Tablets USP 10 mg, 25 mg, and 50 mg1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BSunmark Smooth Antacid Extra Strength1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B0e8341f1-8089-46ff-b142-1fb04209029d1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BParoxetine Tablets, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bd203780c-e770-435a-acff-0162e14836051
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMetolazone Tablets USP2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BZovia 1/35E-28 Zovia 1/50E-28 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP) Revised: August 2006 Rx only1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B40840f67-7066-4bb6-85c1-73eb2618cd264
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BSYNTHROID® (levothyroxine sodium tablets, USP)1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BLEVOTHROID ® (levothyroxine sodium tablets, USP)2
D&C Red No. 30INACTIVE INGREDIENT2S42T2808BMAC TENDERTONE LIP BALM SPF 121
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BThese highlights do not include all the information needed to use OPANA safely and effectively. See full prescribing information for OPANA. OPANA (oxymorphone hydrochloride) tablets, CII Initial U.S. Approval: 19591
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP CIII Rx only3
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCLONAZEPAM TABLETS, USP4
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bbe65d31a-87c1-4f37-a55d-7395bfe3642a2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCLONAZEPAM TABLETS, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BPropranolol Hydrochloride Tablets, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B5ba28222-2808-414b-aa80-e9ec36718e6a1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHypertensolol10
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BORGAN-I NR2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAmoxicillin Tablets, USP2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHydrocodone Bitartrate & Acetaminophen Tablets1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B21b3b8a2-bfed-4945-954d-6a42ea61888f3
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bc7961b19-3f23-4372-b071-34423124d8012
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B71139e30-10c8-4474-b7a3-b575c3fd32f94
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Be3e27c8f-64d5-4e6e-bb2d-5dd3a2e3daa12
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B05e29a60-ebf9-470a-b565-40a6f1f6e1022
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BESTRADIOL TABLETS, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMetoprolol Tartrate1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BIndapamide1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHydrocone Bitartrate and Acetaminophen1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BERYTHROMYCIN Base Filmtab® (erythromycin tablets, USP)1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCARISOPRODOL AND ASPIRIN 200MG/325MG USP Rx Only1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAmitriptyline Hydrochloride Tablets, USP2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B4460a0c0-4c55-4c40-8559-59fef6bf86a41
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BProfessional Labeling Information and Directions for Use These products labeled for sale on prescription only. Guaifenesin Tablets1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDivalproex Sodium Delayed-Release Tablets USP 125 mg, 250 mg and 500 mg1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bb8fb4dcd-2531-40d3-bbfb-ccdc8ce327c42
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHaloperidol Tablets, USP2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B3e823928-c853-4617-acad-21b27174aa7b2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMetoprolol Tartrate Tablets USP Revised: December 2008 Rx only 1743661
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMS CONTIN® (morphine sulfate controlled-release) Tablets CII 15 mg 30 mg 60 mg 100 mg * 200 mg *1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B88f1abdc-f53e-4ff9-b4c1-3cfbc2609b791
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCLONAZEPAM TABLETS, USP CIV 40-8804 Revised — June 2009 Rx Only1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Babfb3e0e-7243-433b-9c8c-4f39e625c9ad1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bff1dddab-72a0-4125-859e-554bece2d2b31
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BRanitidine Tablets, USP and Ranitidine Capsules1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B83d5ef4b-8b46-48b6-ae5a-9a0e493350a01
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Ba6c39757-4551-4493-b27f-5b311fd1fc771
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B0a580de2-95d2-49b6-a1e2-6daf70f1f8c81
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Bee09b4db-4d28-4748-a471-0f7b8c491f541
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808Beb0cd037-1e48-42b1-92ef-4d4ede585bb86
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP CIII Rx only1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BRanitidine Tablets, USP and Ranitidine Capsules1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDIVALPROEX SODIUM DELAYED-RELEASE TABLETS1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAmitriptyline Hydrochloride Tablets, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAmitriptyline Hydrochloride Tablets, USP1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDIVALPROEX SODIUM DELAYED-RELEASE TABLETS4
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B55cf66a2-286d-44d8-8887-17a80939a66f2
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808B83a2a183-7354-4ba8-bd8d-9b6fd1d1a3511
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3983
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BAMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3976
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCLONAZEPAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3971
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BPREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3692
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BESTRADIOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3657
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BERYTHROMYCIN BASE FILMTAB (ERYTHROMYCIN) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3641
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BOPANA (OXYMORPHONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3571
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BOXYCODONE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3560
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDILAUDID (HYDROMORPHONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3297
D&C Red No. 30INACTIVE INGREDIENT2S42T2808BAMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3123
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BINDAPAMIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3043
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BDEPAKOTE (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [ABBVIE INC.]1541
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BSYNTHROID (LEVOTHYROXINE SODIUM) TABLET [ABBVIE INC.]1492
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BESTRADIOL TABLET [BRYANT RANCH PREPACK]1002
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BMORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BOXYCODONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BHALOPERIDOL TABLET [REMEDYREPACK INC. ]160
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BPREMARIN (ESTROGENS, CONJUGATED) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]21